US Patent 7220721 Exendin agonist peptides
Patent 7220721 was granted and assigned to Amylin Pharmaceuticals on May, 2007 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7220721 Exendin agonist peptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.